| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/18/2006 | WO2006036406A3 Live microbial microbicides |
| 05/18/2006 | WO2006035311A3 Group a streptococcus crge protein |
| 05/18/2006 | WO2006032697A3 MODIFIED VPl-CAPSID PROTEIN OF PARVOVIRUS B19 |
| 05/18/2006 | WO2006032436A3 Use of microproteins as tryptase inhibitors |
| 05/18/2006 | WO2006031322A3 Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis |
| 05/18/2006 | WO2006023356A3 Selective vpac2 receptor peptide agonists |
| 05/18/2006 | WO2006020071A3 Vaccines against aids comprising cmv/r-nucleic acid constructs |
| 05/18/2006 | WO2006016275A3 Gastrin-specific interfering rna |
| 05/18/2006 | WO2006008124A3 Molecular diagnostic method and treatment in dementia with lewy bodies |
| 05/18/2006 | WO2005118640A3 A h+-gated ion channel |
| 05/18/2006 | WO2005117577A3 Model for neurodegenerative disorders |
| 05/18/2006 | WO2005116071A3 Snares for pathogenic or infectious agents and uses related thereto |
| 05/18/2006 | WO2005113587A3 Gene products expressed differentially in tumors and use thereof |
| 05/18/2006 | WO2005108611A3 Methods and compositions for the amplification of mutations in the diagnosis of cystic fibrosis |
| 05/18/2006 | WO2005108415A8 Membrane associated molecules |
| 05/18/2006 | WO2005100392A3 Treatment of neuropathic pain with zinc finger proteins |
| 05/18/2006 | WO2005087806A3 Cd38 splice variant and uses thereof |
| 05/18/2006 | WO2005077044A3 Rational design and engineering of proteins and peptides for immunomodulation |
| 05/18/2006 | WO2005067491A3 Toxin complex proteins and genes from xenorhabdus bovienii |
| 05/18/2006 | WO2005060995A3 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 05/18/2006 | WO2005035550A3 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 05/18/2006 | WO2005009339A3 Inflammatory bowel diseases |
| 05/18/2006 | WO2004109292A3 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs |
| 05/18/2006 | WO2004074445A3 Model for studying the role of genes in tumor resistance to chemotherapy |
| 05/18/2006 | WO2003106616A3 MEMBRANE-ANCHORED ß2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES |
| 05/18/2006 | WO2003100082A3 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 05/18/2006 | WO2002096356A3 HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR |
| 05/18/2006 | US20060107353 Plant bioreactors |
| 05/18/2006 | US20060107351 Cell visual characteristic-modifying sequences |
| 05/18/2006 | US20060107345 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| 05/18/2006 | US20060107344 Organ preferential genes identified by T-DNA insertional mutagenesis of rice |
| 05/18/2006 | US20060107343 Plant cells and plant bodies with modified cell growth, development and differentiation |
| 05/18/2006 | US20060107339 Transgenic cell comprising human leukocyte antigen binding peptide for use as tools diagnosis, prevention and treatment of cell proliferative disorders; genetic vaccines |
| 05/18/2006 | US20060107337 Elimination of endogenous porcine retrovirus |
| 05/18/2006 | US20060106734 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse |
| 05/18/2006 | US20060106205 Process for protein extraction |
| 05/18/2006 | US20060106204 Bifunctional energy-reversible acyl-compositions |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106201 Novel hemopoietin receptor protein, NR12 |
| 05/18/2006 | US20060106200 Soluble, functional apoptotic protease-activating factor 1 fragments |
| 05/18/2006 | US20060106199 Streptavidin-binding peptide |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060106120 Method of degrading plastic and process for producing useful substance using the same |
| 05/18/2006 | US20060105994 Treatment of prostate cancer |
| 05/18/2006 | US20060105981 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1) |
| 05/18/2006 | US20060105977 Desmoglein 4 is a novel gene involved in hair growth |
| 05/18/2006 | US20060105959 Organic compounds with biological action as thrombin inhibitors and use thereof |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105954 Glucagon-like peptide-2 and its therapeutic use |
| 05/18/2006 | US20060105953 Polynucleotide encoding polypeptide which is protected from proteosomal degradation by cleavage of linking group; |
| 05/18/2006 | US20060105951 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 05/18/2006 | US20060105949 Pharmaceutical preparations and methods for inhibiting tumors |
| 05/18/2006 | US20060105948 GLP-2 derivatives |
| 05/18/2006 | US20060105947 Novel chimeric analgesic peptides |
| 05/18/2006 | US20060105942 Inhibition of cell division based use of analogs of neuropeptide y |
| 05/18/2006 | US20060105472 Reduction of non-specific binding in assays |
| 05/18/2006 | US20060105470 For detecting early conception factor in a body fluid from an animal comprising the antibodies which specifically bind early conception factor |
| 05/18/2006 | US20060105456 Method for purifying adenoviruses |
| 05/18/2006 | US20060105451 Genetically engineered P30 antigen improved antigen cocktail, and uses thereof |
| 05/18/2006 | US20060105446 Biodegradable, resistant to nitrate salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 05/18/2006 | US20060105445 Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105427 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/18/2006 | US20060105426 mcFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 05/18/2006 | US20060105424 Nucleic acids which code for protein from Acremonium chrysogenum; host cells |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105406 Cytoplasmic antigens for detection of Candida |
| 05/18/2006 | US20060105403 Braca1/acc alpha molecular complexes, diagnostic and therapeutic applications |
| 05/18/2006 | US20060105387 Transferrin fusion proteins libraries |
| 05/18/2006 | US20060105385 Xenobiotic related induction of gene expression |
| 05/18/2006 | US20060105381 Polymorphisms of the OCTN1 cation transporters associated with inflammatory bowel disorders |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060105376 Novel full-length cDNA |
| 05/18/2006 | US20060105364 Best's macular dystrophy gene |
| 05/18/2006 | US20060105347 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 05/18/2006 | US20060105346 Human prostaglandin FP receptor variants and methods of using same |
| 05/18/2006 | US20060105340 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 05/18/2006 | US20060105330 Diagnostics and remedies for malignant brain tumor |
| 05/18/2006 | US20060105323 Multi-reporter gene model for toxicological screening |
| 05/18/2006 | US20060105320 Electrical conductors and devices from prion-like proteins |
| 05/18/2006 | US20060105013 Osteopontin-coated surfaces and methods of use |
| 05/18/2006 | US20060104993 Methods and compositions for immunizing against Pseudomonas infection |
| 05/18/2006 | US20060104992 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating HIV |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104989 Essential novel bacterial polypeptides |
| 05/18/2006 | US20060104988 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 05/18/2006 | US20060104987 Rhesus D antigen encoded by a nucleic acid molecule carrying one or more specific missense mutations used for determining whether a patient that is in need of a blood transfusion needs to be transfused with RhD negative blood |
| 05/18/2006 | US20060104981 Prophylactic/therapeutic agent for cancer |
| 05/18/2006 | US20060104980 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 05/18/2006 | US20060104978 Methods and compositions for PDGF-C activation and inhibition |
| 05/18/2006 | US20060104977 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 05/18/2006 | US20060104974 CD147 binding molecules as therapeutics |
| 05/18/2006 | US20060104972 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 05/18/2006 | US20060104964 Recombinant sequence, its preparation and use |
| 05/18/2006 | US20060104953 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof |
| 05/18/2006 | US20060104935 Controlled dissolution crosslinked protein crystals |
| 05/18/2006 | US20060104900 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 05/18/2006 | DE10063879B4 Nucleinsäuren, die vacuoläre Invertasen codieren, Pflanzenzellen und Pflanzen, die diese enthalten sowie ihre Verwendung Nucleic acids encoding the vacuolar invertase, plant cells and plants containing them and their use |
| 05/18/2006 | CA2595757A1 Insecticidal polypeptides and methods of use thereof |
| 05/18/2006 | CA2587469A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |